1 |
Projean D, Lessard E, Ducharme MP, Ducharme J. 2007. Use of Freund's Complete Adjuvant (FCA) in inflammatory pain models: Consequences on the metabolism and pharmacokinetics of the non-peptidic delta receptor agonist SNC80 in the rat. Xenobiotica 37: 870-883.
DOI
ScienceOn
|
2 |
Bacon A, Makin J, Sizer PJ, Jabbal-Gill, Hinchcliffe M, Illum L, Chatfield S, Roberts M. 2000. Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens. Infect Immun 68: 5764-5770.
DOI
ScienceOn
|
3 |
McNeela EA, Jabbal-Gill I, IlIum L, Pizza M, Rappuoli R, Podda A, Lewis DJ, Mills KH. 2004. Intranasal immunization with genetically detoxified diphtheria toxin induces T eel! responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan. Vaccine 22: 909-914.
DOI
ScienceOn
|
4 |
Mi FL, Shyu SS, Chen CT, Schoung JY. 1999. Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigenadsorbed microsphere and in vitro release. Biomaterials 20: 1603-1612.
DOI
ScienceOn
|
5 |
Frey A, Di Canzio J, Zurakowski D. 1998. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 221: 35-41.
DOI
ScienceOn
|
6 |
van def Lubben IM, Kersten G, Fretz MM, Beuvery C, Coos Verhoef J, Junginger HE. 2003. Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine 21: 1400-1408.
DOI
ScienceOn
|
7 |
Seo JY, Pyo HJ, Lee SM, Lee JI, Kim TJ. 2009. Expression of 4 truncated fragments of Pasteurella multocida toxin and their immunogenicity. Can J Vet Res 73: 184-189.
|
8 |
Kim TJ, Kim KH, Lee JI. 2007. Stimulation of mucosal and systemic antibody responses against recombinant transferrin- binding protein B of Actinobacillus pleuropneumoniae. J Vet Med Sci 69: 535-539.
DOI
ScienceOn
|
9 |
lIlum L. 1998. Chitosan and its use as a pharmaceutical excipient. Pharm Res 15: 1326-1331.
DOI
ScienceOn
|
10 |
IlIum L, Farraj NF, Davis SS. 1994. Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res 11: 1186-1189.
DOI
ScienceOn
|